now they report to johnny ives. on's always been in ivesol -- johnny has always been in control. emily: does it signal anything about issues with design. >> it is about how important is johnny ives influence. they have always emphasized it is a team effort. , thereents apple files are 20 people on that. so they see it as a team effort. it might not make a huge difference. emily: the iphone x is a huge design shift. do you imagine he was involved with that? >> he definitely goes into that andio every now and again makes a call on what he is in favor of. formalizes what has been less formal. webb and our guest in los angeles a, thank you. and a venture capitalist. what he is looking at, next. this is bloomberg. ♪ alex webb and our guest in los angeles, thank you. investing from a venture capitalist. what he is looking at, next. this is bloomberg. ♪ ♪ years, tim draper has been one of the most successful venture capital investors in silicon valley. he is now turning his attention to how to make it easier for tech startu

johnny ives, one of the most well-known members of the crew has retake inbs management of the productn teams at apple. we will be discussing that later on with mark gurman. this is a bloomberg scoop. drugmaker,sraeli considering cutting 2000 jobs as considers reducing expenses. and star not international after -- steinhoff international, there was an accounting scandal that threatened the future of this stock. the of course, looking at bond market, the big action was the u.s. jobs report. solid, but not so much wage growth people are worried about hikingceleration in the cycle. muted reaction in treasuries. the 10-year yield dipped earlier in the session in the immediate wake of the report, but i guess that risk on five to the overall market, as scarlet was discussing, did look long. so, a hair of steepening a couple days on that. u.s. dollar, slight gains for the dollar index. i am showing you the number. just over 8.5%. dayave the fifth straight of gains. 25 basis points for next week, too, just keeping an eye on the level of the dollar there rather than anything else. a quick look,

josh >> michelle, news on apple's johnny ive, company's chief design officer, jony ive responsible forrdware, user interface. he's going to be taking back day-to-day management of that design team. you recall he stepped back from that kind of day-to-day role in 2015 in part so that he could focus his time and effort on apple's new corporate campus, apple port now apple's telling cnbc in a statement "with the completion of apple park, apple's design leaders and teams are again reporting directly to jony ive who remains focused purely on design." this news means that as well apple's two vps of design, who had been reporting to ceo tim cook, they'll now report directly to sir jony ive guys, back to you. >> lefs busines he was busy wore buildings. he couldn't focus on products -- >> it's a big office building. >> it's a campus. >> i get that, but, i mean, you never want to hear that your customer-facing guy is working on the internal building. >> that's why my battery's doing so poorly. no, no, that's not design. >> revolution now, not evolution from apple maybe we're just overthinking it.

. >>> other apple news the company announced that long-time executive johnny ive resumed day to day designole he stepped back from that role in 2015 in large part because he was spending a lot more time working on the design of the new headquarters and a whole other host of other projects but to see him back in the mix working on the could he vices themselves and not to say that he wasn't involved, but in terms of hands on -- >> so your friend ackman, he was totally out of this now. >> that was a brilliant -- no one else saw >> that was like bitcoin >> yeah. >> in terms of your kind of magnitude -- >> pennies, wasn't it? >> yeah. >> anyway, okay. >> all right >> experts in the field of hematology are gathering in atlanta for the annual ash conference meg terrell has a special guest. good morning, meg. >> good morning. joining us now -- you guys had some of the probably most exciting data from analysts in wall street and medicines perspective here at the conference with your partner data with blue bird in multi multi-myloma this is for patients that have gone through seven therapies already